Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Authoritative Sources The NEJM phase 2 retatrutide trial reports published obesity research data and study limitations
This stands in contrast to tirzepatide trials , where hair loss was specifically tracked and reported at rates of 4.9-5.3% across dose groups compared to 0.9% with placebo
Annals of General Psychiatry, 5 , S306
Register Interest
US$ 25.47
US$ 22.14
US$ 29.29
US$ 27.89
US$ 20.14
US$ 21.59
US$ 22.52
US$ 23.17
